Deepa Jewellers and Cotec Healthcare Secure SEBI Approval for Upcoming IPOs

Deepa Jewellers and Cotec Healthcare have recently received final approval from the Securities and Exchange Board of India (Sebi) to proceed with their initial public offerings (IPOs), marking a significant development within the Indian primary market, particularly in the jewellery and pharmaceutical sectors. Deepa Jewellers is set to raise up to Rs 250 crore through a combination of a fresh issue and an offer for sale, consisting of 1.18 crore shares. Established in 2016, the Hyderabad-based company focuses on processing 22-karat gold jewellery, primarily catering to the wholesale market across southern Indian states, while Cotec Healthcare operates as a contract development and manufacturing organization, producing a wide range of pharmaceutical formulations.

According to market analysts, the grey market sentiment surrounding both IPOs appears cautiously optimistic. Investors are eager to assess the valuations and potential demand for shares, particularly given Deepa Jewellers’ established presence in the southern jewellery market and the growing relevance of Cotec Healthcare in the pharmaceutical sector. The primary market has been active in recent months, suggesting a heightened interest among investors in diversified sectors, thus contributing positively to potential subscription rates for these IPOs once they are officially launched.

For Indian investors, the forthcoming IPOs from Deepa Jewellers and Cotec Healthcare carry the potential for lucrative investments, especially within their respective industries, which are witnessing robust growth. The aggressive strategies adopted by both companies, along with their established operational frameworks, could enhance investor confidence. As always, investors should consider their personal risk tolerance and investment horizons before engaging in the IPO market, keeping an eye on the pricing strategies and overall market conditions during the launch periods of these companies.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)